Avastin

151,00 300,00 

Therapeutic VEGF-A-antibody from the original Avastin commercial drug targeting the VEGF-A-antigen, also referred to as Avastin antibody.

Category Product Concentration [mg/mL] Volume per Vial [µL] Quantity per vial [mg] Batch Number Storage [°C] Original therapeutic expiry date Certificate of Analysis (CoA)* PriceQuantityTotal
aliquot 251203H0152B21-80°09/2017no 185,00 
-
+
185,00 
spinner
aliquot 251203H0156B21-80°03/2018no 185,00 
-
+
185,00 
spinner
aliquot 25802B7219H04-80°06/2018no 151,00 
-
+
151,00 
spinner
aliquot 25802B7223H06-80°09/2018no 151,00 
-
+
151,00 
spinner
aliquot 25802B7223H17-80°09/2018no 151,00 
-
+
151,00 
spinner
aliquot 25802B7226H07-80°12/2018no 151,00 
-
+
151,00 
spinner
aliquot 25802B7230H14-80°03/2019no 151,00 
-
+
151,00 
spinner
aliquot 25802B7234H02-80°08/2019no 151,00 
-
+
151,00 
spinner
aliquot 25802B8020H05-80°10/2019no 151,00 
-
+
151,00 
spinner
aliquot 25802B8800H282-8°/-80°03/2021yes 151,00 
-
+
151,00 
spinner
dilution11000,1--80°NOT APPLICABLEno 300,00 
-
+
300,00 
spinner

Category: SKU: B7219H04

Description

Additional information

Category

aliquot, dilution

Therapeutic molecule

Bevacizumab

Antigen

VEGF-A

Product Concentration [mg/mL]

1, 25

Volume per Vial [µL]

80, 100, 120

Quantity per vial [mg]

0, 0,1, 2, 3

Batch Number

B7219H04, B7223H06, B7223H17, B7226H07, B7230H14, B7234H02, B8020H05, NOT APPLICABLE, H0152B21, H0156B21, -, B8030H10, B8800H28

Storage [°C]

-, -80°, 2-8°/-80°

Original therapeutic expiry date

-, 03/2018, 03/2019, 03/2021, 06/2018, 08/2019, 09/2017, 09/2018, 10/2019, 12/2018, NOT APPLICABLE

Certificate of Analysis (CoA)*

n.a., no, yes